Capital Flow Monitor · Sponsors · CIK 2038826
Bectas Therapeutics, Inc.
3262 WESTHEIMER ROAD, HOUSTON, TX, 77098 · 617-834-3476
Biotechnology · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$10.0M
Sold
$5.6M
% sold
55.5%
Investors
13
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-08 | D/A ·current | 506(b) | $10.0M | $5.6M | 55.5% | 13 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Ronan O'Hagan — Executive Officer / Director, Houston, TX
-
Lynda Chin — Director, Houston, TX
1 other raise
- Regenimo Biosciences, Inc. $2.0M of $2.0M · 100.0%
- Jon A. Brilliant — Executive Officer, Houston, TX
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.